Correlation Between Bank of America and Atara Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Bank of America and Atara Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Atara Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Atara Biotherapeutics, you can compare the effects of market volatilities on Bank of America and Atara Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Atara Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Atara Biotherapeutics.
Diversification Opportunities for Bank of America and Atara Biotherapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Bank and Atara is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Atara Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atara Biotherapeutics and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Atara Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atara Biotherapeutics has no effect on the direction of Bank of America i.e., Bank of America and Atara Biotherapeutics go up and down completely randomly.
Pair Corralation between Bank of America and Atara Biotherapeutics
Considering the 90-day investment horizon Bank of America is expected to generate 2.62 times less return on investment than Atara Biotherapeutics. But when comparing it to its historical volatility, Bank of America is 4.31 times less risky than Atara Biotherapeutics. It trades about 0.27 of its potential returns per unit of risk. Atara Biotherapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 958.00 in Atara Biotherapeutics on August 31, 2024 and sell it today you would earn a total of 260.00 from holding Atara Biotherapeutics or generate 27.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank of America vs. Atara Biotherapeutics
Performance |
| Timeline |
| Bank of America |
| Atara Biotherapeutics |
Bank of America and Atara Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Atara Biotherapeutics
The main advantage of trading using opposite Bank of America and Atara Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Atara Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atara Biotherapeutics will offset losses from the drop in Atara Biotherapeutics' long position.| Bank of America vs. RLJ Lodging Trust | Bank of America vs. Aquagold International | Bank of America vs. Stepstone Group | Bank of America vs. Morningstar Unconstrained Allocation |
| Atara Biotherapeutics vs. Fate Therapeutics | Atara Biotherapeutics vs. Sana Biotechnology | Atara Biotherapeutics vs. Caribou Biosciences | Atara Biotherapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |